Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,400.96
(
-0.16%
)
US TECH 100
28,496.00
(
0.73%
)
Dow Jones
49,760.56
(
0.11%
)
Brent Oil
106.15
(
0.37%
)
Bitcoin
80,691.06
(
0.25%
)
News Focus
News Focus
Post# of 518327
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Reyeton

Send PM Follow Ignore
Followers 20
Posts 1291
Boards Moderated 0
Alias Born 04/13/2013

Reyeton

Re: Jimmy6969 post# 83254

Saturday, 12/10/2016 11:50:58 PM

Saturday, December 10, 2016 11:50:58 PM

Post# of 518327

The amyloid hypothesis is dead.

Agree 100%. Unfortunately, the big pharmas with deep pockets keep this scam going to the detriment of those suffering from Alzheimer's Disease. Finding favor now that in a sub-group of patients on BIIB's AD drug, only 35% experience brain swelling, down from 55%, is mind boggling. Anavex 2-73 is the best hope for AD sufferers. Maybe AF will have an epiphany and publish an upbeat piece on the results of Anavex Clinical Trial. Wouldn't that level the playing field?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News